08:02In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
04:25Neuronal Death Assay to Evaluate Cell Death in Ex Vivo Epilepsy Model
12:44Use of LysoTracker to Detect Programmed Cell Death in Embryos and Differentiating Embryonic Stem Cells
01:30TUNEL Assay for Detecting Apoptotic Cell Death in a Brain Slice
An Introduction to Cell Death
12:08Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 19, 2026

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
Takahiro Yamazaki1, Aitziber Buqué1, Marissa Rybstein1
1Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA.
Cancer cells can die in ways that trigger immune responses, but predicting this immunogenic cell death (ICD) is challenging. This study introduces two methods to assess ICD in mice, aiding cancer immunotherapy research.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: